NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02668653,Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML),https://clinicaltrials.gov/study/NCT02668653,QuANTUM-First,COMPLETED,"Quizartinib is an experimental drug. It is not approved for regular use. It can only be used in medical research.

Adults might be able to join this study after bone marrow tests show they have a certain kind of blood cancer (FLT3-ITD AML).

Participants will have an equal chance of receiving quizartinib or placebo along with their chemotherapy.",YES,Acute Myeloid Leukemia|Leukemia,DRUG: Chemotherapy|DRUG: Quizartinib|DRUG: Placebo,"Overall Survival in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Overall survival is defined as the time from randomization until death from any cause., Date of randomization to the date of death due to any cause, up to approximately 3 years after enrollment","Event-free Survival in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Event-free survival (EFS) is the time from randomization to the earliest date of either refractory disease (or treatment failure \[TF\]), relapse, or death from any cause. Refractory disease is defined as complete remission never achieved during Induction (CR: \>1000 neutrophils, \>100,000 platelets, \<5% blasts, and other \[defined as absence of extramedullary disease \[EMD\], blasts with rods, and leukemic blasts\]). For refractory disease, EFS event date is Day 1 (randomization). Relapse after CR is defined as ≥5% blasts, leukemic blasts, extramedullary leukemia, and presence of rods. This analysis is based on a response assessment with TF defined as not achieving response of CR, using a 42- day window from the start of the last cycle in Induction for CR evaluation., Date of randomization to the date of refractory disease, relapse, or death, up to approximately 3 years after enrollment|Complete Remission (CR) Rate at the End of Induction in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Complete remission (CR) rate is defined as the percentage of participants achieving CR, defined as \<5% blasts, \>1000 neutrophils, \>100,000 platelets, and other \[defined as absence of extramedullary disease \[EMD\], blasts with rods, and leukemic blasts\], after induction, Approximately Cycle 1 Day 21 (Induction) to end of Induction, up to approximately 120 days (each Induction cycle is up to 60 days)|Composite CR Rate at the End of Induction in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Composite complete remission (CRc) rate is defined as the percentage of participants whose best response is complete remission (CR), defined as \<5% blasts, \>1000 neutrophils, \>100,000 platelets, and other \[defined as absence of extramedullary disease \[EMD\], blasts with rods, and leukemic blasts\], or CR with incomplete neutrophil or platelet recovery (CRi) at the end of first Induction cycle., Approximately Cycle 1 Day 21 (Induction) to end of Induction, up to approximately 120 days (each Induction cycle is up to 60 days)|Number of Participants With Treatment-emergent Adverse Events Occurring in ≥10% Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, A treatment-emergent adverse event (TEAE) is defined as an adverse event that occur, having been absent before first dose of quizartinib or placebo, or have worsened in severity after initiating quizartinib or placebo. Adverse events collected more than 30 days after the last dose of quizartinib/placebo will not be considered TEAEs unless they are considered drug-related., Date of first dose up to 30 days after last dose, up to 36 cycles following continuation (approximately 6 years 11 months, each cycle is 28 days)|Number of Participants Achieving CR With FLT3-ITD Minimal Residual Disease Negativity at the End of Induction in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Complete remission (CR) is defined as participants achieving CR defined as \<5% blasts, \>1000 neutrophils, \>100,000 platelets, and other \[defined as absence of extramedullary disease \[EMD\], blasts with rods, and leukemic blasts\]. Minimal or measurable residual disease is the presence of a small number of leukemic cells in the bone marrow of patients with AML below the level of detection using conventional morphologic assessment., Approximately Cycle 1 Day 21 (Induction phase) to end of Induction phase, up to approximately 120 days (each Induction cycle is up to 60 days)|Number of Participants Achieving Composite CR With FLT3-ITD Minimal Residual Disease Negativity at the End of Induction in Participants With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia, Composite complete remission (CRc) is defined as \<5% blasts, \>1000 neutrophils, \>100,000 platelets, and other \[defined as absence of extramedullary disease \[EMD\], blasts with rods, and leukemic blasts\], or CR with incomplete neutrophil or platelet recovery (CRi). Minimal or measurable residual disease is the presence of a small number of leukemic cells in the bone marrow of patients with AML below the level of detection using conventional morphologic assessment., Approximately Cycle 1 Day 21 (Induction phase) to end of Induction phase, up to approximately 120 days (each Induction cycle is up to 60 days)|Pharmacokinetic Parameter Area Under the Concentration Versus Time Curve at Steady State, AUCss was assessed by population Pharmacokinetic (PK) analysis during Cycle 1 of each phase., Induction Cycle 1: Day 8, predose, 2-4 hours (hr) postdose on Days 8, 15, 21; Consolidation Cycle 1: Day 6, predose, 2-4 hr postdose on Days 6, 13, 19; Continuation Cycle 1: 2-4 hr postdose, Days 1, 8, 15; Cycle 2 Days 1 and 15 (each cycle, 28 days)|Pharmacokinetic Parameter Steady State, Maximum Plasma Concentration (Css,Max), Css,max was assessed by population PK analysis during Cycle 1 of each phase., Induction Cycle 1: Day 8, predose, 2-4 hours (hr) postdose on Days 8, 15, 21; Consolidation Cycle 1: Day 6, predose, 2-4 hr postdose on Days 6, 13, 19; Continuation Cycle 1: 2-4 hr postdose, Days 1, 8, 15; Cycle 2 Days 1 and 15 (each cycle, 28 days)|Pharmacokinetic Parameter Time to Maximum Plasma Concentration Steady State (Tmax,ss), Tmax,ss was assessed by population PK analysis during Cycle 1 of each phase., Induction Cycle 1: Day 8, predose, 2-4 hours (hr) postdose on Days 8, 15, 21; Consolidation Cycle 1: Day 6, predose, 2-4 hr postdose on Days 6, 13, 19; Continuation Cycle 1: 2-4 hr postdose, Days 1, 8, 15; Cycle 2 Days 1 and 15 (each cycle, 28 days)",,Daiichi Sankyo,,ALL,"ADULT, OLDER_ADULT",PHASE3,539,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",AC220-A-U302|2015-004856-24|173667,2016-09-01,2021-08-13,2023-06-16,2016-01-29,2022-10-05,2024-08-06,"University of Florida (UF) Health Shands Hospital, Gainesville, Florida, 90095, United States|The University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Franciscan St. Francis Health Indianapolis, Indianapolis, Indiana, 46237, United States|University of Kentucky Chandler Medical Center, Lexington, Kentucky, 40536, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|NY Medical College - Hudson Valley Hematology Oncology Associates, Valhalla, New York, 10595, United States|Duke Clinical Research Institute, Durham, North Carolina, 27710, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, 44106, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|West Virginia University Hospitals, Inc., Morgantown, West Virginia, 26506, United States|Sanatorio Britanico, Rosario, Santa Fe, S2000CVB, Argentina|Sanatorio Allende, Córdoba, X5000JHQ, Argentina|Calvary Mater Newcastle, Waratah, New South Wales, 2298, Australia|Townsville Hospital (TTH), Douglas, Queensland, 4814, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|AZ Sint-Jan Brugge-Oostende AV, Brugge, 8000, Belgium|Universitair Ziekenhuis Gent, Gent, 9000, Belgium|UCL Mont-Godinne, Yvoir, 5530, Belgium|Hospital Amaral Carvalho, Brasília, 70750-521, Brazil|Hospital do CEPON, Brasília, 70750-521, Brazil|Instituto do Cancer do Estado de São Paulo, Brasília, 70750-521, Brazil|Santa Casa de Misericórdia de Porto Alegre, Brasília, 70750-521, Brazil|Hospital da Cidade de Passo Fundo, Passo Fundo, 99010-260, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, 90035-903, Brazil|University Multiprofile Hospital for Active Treatment ""Dr. G. Stranski"" EAD, Pleven, 5800, Bulgaria|University Multiprofile Hospital for Active Treatment ""Sveti Georgi"" EAD, Sofia, 1000, Bulgaria|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|University of Alberta Hospital, Edmonton, Alberta, T6G-3G3, Canada|Vancouver General Hospital (VGH), Vancouver, British Columbia, V5Z 1M9, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 1X5, Canada|Peking University First Hospital, Beijing, 100034, China|The General Hospital of People's Liberation Army (301 Hospital), Beijing, 100853, China|Fujian Medical University Union Hospital, Fuzhou, 350001, China|Guangdong General Hospital, Guangzhou, 510030, China|Lanzhou University Second Hospital, Lanzhou, 730030, China|Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School, Shanghai, 200025, China|West China Hospital, Sichuan University, Taiyuan, 30001, China|Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, 300020, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015, China|Tang Du Hospital, Fourth Military Medical University, Xi'an, 710038, China|Henan Cancer Hospital, Zhengzhou, 450008, China|Klinička Bolnica Dubrava, Zagreb, 10000, Croatia|Klinička Bolnica Merkur, Zagreb, 10000, Croatia|Klinički Bolnički Centar Zagreb, Zagreb, 10000, Croatia|Fakultní Nemocnice Hradec Králové, Hradec Kralove, 500 05, Czechia|Fakultní Nemocnice Olomouc, Olomouc, 775 20, Czechia|Fakultní Nemocnice Ostrava, Ostrava, 708 52, Czechia|Fakultni Nemocnice Plzen, Plzen, 304 60, Czechia|Vseobecna Fakultni Nemocnice, Ustav hematologie a krevni transfuze (UHKT), Praha 2, 128 20, Czechia|Hospital A. Michallon, Grenoble, 38043, France|Centre Hospitalier de Versailles - Hôpital André Mignot, Le Chesnay, 78150, France|Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez, Lille, 59037, France|Centre Léon Bérard, Lyon, 69373, France|L'Institut Paoli - Calmettes, Marguerittes, 13009, France|Hôpital de la Conception, Marseille, 13385, France|CHRU Montpellier - Saint Eloi, Montpellier, 34295, France|Hôpital Saint-Antoine, Paris, 75012, France|Hôpital Saint-Louis, Paris, 75475, France|Hôpital Haut-Lévêque, Pessac, 33604, France|Centre Hospitalier Lyon-Sud, Pierre Benite, 69495, France|Centre Henri Becquerel - Centre de Lutte Contre le Cancer, Rouen, 76038, France|Centre Hospitalier Universitaire de Toulouse - Hôpital Purpan, Toulouse, 31059, France|HELIOS Klinikum Bad Saarow, Bad Saarow, 15526, Germany|Charité - Universitätsmedizin Berlin, Berlin, 10117, Germany|Städtisches Klinikum Braunschweig gGmbH, Braunschweig, 38114, Germany|Marien Hospital Düsseldorf GmbH, Düsseldorf, 40479, Germany|Universitätsklinikum Essen, Essen, 45122, Germany|Universitätsklinikum Frankfurt, Frankfurt am Main, 60590, Germany|Universitätsklinikum Halle (Saale), Halle, 6120, Germany|Evangelisches Krankenhaus Hamm gGmbH, Hamm, 59063, Germany|Medizinische Hochschule Hannover (MHH), Hannöver, 30625, Germany|Universitätsklinikum Münster, Heidelberg, 69115, Germany|Universitätsklinikum Tübingen, Heidelberg, 69115, Germany|Universitätsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitätsklinikum Leipzig, Leipzig, 4103, Germany|Stauferklinikum Schwäbisch Gmünd, Mutlangen, 73557, Germany|HELIOS Klinikum Wuppertal, Wuppertal, 42283, Germany|Prince of Wales Hospital, Shatin, Hong Kong|Markusovszky Egyetemi Oktatókórház, Budapest, 1051, Hungary|Szegedi Tudományegyetem, Budapest, 1051, Hungary|Semmelweis Egyetem, Budapest, 1083, Hungary|Debreceni Egyetem Klinikai Központ, Debrecen, 4032, Hungary|Pecsi Tudomanyegyetem Klinikai Központ, Pécs, 7624, Hungary|Markusovszky Egyetemi Oktatókórház, Szombathely, 9700, Hungary|Assaf Harofeh Medical Center, Be'er Ya'aqov, Tsifrin, 70300, Israel|Bnai Zion Medical Center, Haifa, 31048, Israel|Rambam Medical Center, Haifa, 31096, Israel|Hadassah University Medical Center, Jerusalem, 91120, Israel|Rabin Medical Center - Beilinson Hospital, Petaẖ Tiqwa, 49100, Israel|The Chaim Sheba Medical Center, Ramat-Gan, 52621, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|Azienda Ospedaliera Nazionale SS.Antonio e Biagio e Cesare Arrigo, Alessandria, 15121, Italy|Azienda Sanitaria Locale 13 - Ospedale ""C. e G. Mazzoni""- Ascoli Piceno, Ascoli Piceno, 63100, Italy|Azienda Ospedaliero - Universitaria Consorziale Policlinico di Bari, Bari, 70124, Italy|Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi, Bologna, 40138, Italy|IRCCS AOU San Martino - IST, Genova, 16132, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy|A.O.R.N. ""A. Cardarelli"", Napoli, 80131, Italy|Azienda Ospedaliero Universitaria Maggiore della Carità di Novara, Novara, 28100, Italy|Azienda Ospedaliero - Universitaria San Luigi Gonzaga, Orbassano, 10043, Italy|Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo, 90146, Italy|Ospedale S. Maria delle Croci - Ravenna, Ravenna, 48121, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, 133, Italy|Ospedale S. Eugenio, Roma, 133, Italy|Policlinico Tor Vergata, Roma, 133, Italy|IRCCS Ospedale San Raffaele, Roma, 20132, Italy|Azienda Ospedaliero-Universitaria Careggi, Roma, 50134, Italy|Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara, Roma, 56126, Italy|Azienda Ospedaliera Universitaria ""Federico II"", Roma, 80131, Italy|Istituto Clinico Humanitas, Rozzano, 20089, Italy|Azienda Ospedaliera Universitaria OO.RR. San Giovanni di Dio Ruggi d'Aragona, Salerno, 84131, Italy|Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy|Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino - Ospedale Molinette, Torino, 10126, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, 10128, Italy|ASST dei Sette Laghi - Ospedale di Circolo e Fondazione Macchi Varese, Varese, 21100, Italy|National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, 460-0001, Japan|Nagoya University Hospital, Nagoya, Aichi, 466-8560, Japan|Toyohashi Municipal Hospital, Toyohashi, Aichi, 441-8570, Japan|Ehime Prefectural Central Hospital, Matsuyama, Ehime, 790-0024, Japan|University of Fukui Hospital, Yoshida, Fukui, 910-1193, Japan|Kyushu University Hospital, Higashi, Fukuoka, 812-8582, Japan|Gunmaken Saiseikai Maebashi Hospital, Maebashi, Gunma, 371-0821, Japan|Gunma University Hospital, Maebashi, Gunma, 371-8511, Japan|Chugoku Central Hospital, Fukuyama, Hiroshima, 720-0001, Japan|Sapporo Hokuyu Hospital, Sapporo, Hokkaido, 003-0006, Japan|Yokohama City University Hospital, Yokohama, Kanagawa, 236-0004, Japan|National Hospital Organization Sendai Medical Center, Sendai, Miagi, 983-8520, Japan|Tenri Hospital, Tenri, Nara, 632-8552, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3192, Japan|Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyō-Ku, Tokyo, 113-8677, Japan|The Jikei University Hospital, Minato-Ku, Tokyo, 105-0003, Japan|Akita University Hospital, Akita, 010-8543, Japan|Aomori Prefectural Central Hospital, Aomori, 030-8553, Japan|Chiba Aoba Municipal Hospital, Chiba, 260-0852, Japan|Kameda Medical Center - Kameda General Hospital, Chiba, 296-0041, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Gifu Municipal Hospital, Gifu, 500-8513, Japan|National Hospital Organization Kagoshima Medical Center, Kagoshima, 892-0853, Japan|Kobe City Medical Center General Hospital, Kobe, 650-0047, Japan|National Hospital Organization Kumamoto Medical Center, Kumamoto, 860-0008, Japan|Nagasaki University Hospital, Nagasaki, 852-8501, Japan|Osaka City General Hospital, Osaka, 534-0021, Japan|Osaka Red Cross Hospital, Osaka, 543-8555, Japan|NTT Medical Center Tokyo, Tokyo, 141-8625, Japan|Inje University Haeundae Paik Hospital, Busan, 48108, Korea, Republic of|Pusan National University Hospital, Busan, 49241, Korea, Republic of|Kyungpook National University Hospital, Daegu, 41944, Korea, Republic of|Yeungnam University Medical Center, Daegu, 42415, Korea, Republic of|Daegu Catholic University Medical Center, Daegu, 42472, Korea, Republic of|Chonnam National University Hwasun Hospital, Hwasun, 58128, Korea, Republic of|Gachon University Gil Hospital, Incheon, 21565, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, 13620, Korea, Republic of|Seoul National University Hospital, Seoul, 3080, Korea, Republic of|Severance Hospital, Seoul, 3722, Korea, Republic of|SoonChunHyang University Seoul Hospital, Seoul, 4401, Korea, Republic of|Konkuk University Medical Center, Seoul, 5030, Korea, Republic of|Asan Medical Center, Seoul, 5505, Korea, Republic of|Samsung Medical Center, Seoul, 6351, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, 6591, Korea, Republic of|Korea University Guro Hospital, Seoul, 8308, Korea, Republic of|Ajou University Hospital, Sŏwŏn, 16499, Korea, Republic of|Ulsan University Hospital (UUH), Ulsan, 44033, Korea, Republic of|Szpital Uniwersytecki w Krakowie, Kraków, 31-501, Poland|Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka, Słupsk, 76-200, Poland|Instytut Hematologii i Transfuzjologi, Warszawa, 00-957, Poland|Samodzielny Publiczny Szpital Kliniczny Nr. 1 we Wrocławiu, Warszawa, 50367, Poland|Centro Hospitalar e Universitário de Coimbra, EPE - Hospitais da Universidade de Coimbra, Coimbra, 3000-075, Portugal|Centro Hospitalar Lisboa Central, EPE - Hospital Santo António dos Capuchos, Lisboa, 1169050, Portugal|Centro Hospitalar do Porto, EPE - Hospital Geral de Santo António, Porto, 4099-001, Portugal|Instituto Português Oncologia do Porto Francisco Gentil, EPE, Porto, 4200-072, Portugal|Centro Hospitalar de São João, EPE - Hospital de São João, Porto, 4200-319, Portugal|Institutul Regional de Oncologie Iași, Bucuresti, 20125, Romania|Spitalul Clinic Colentina, Bucuresti, 20125, Romania|Spitalul Clinic Coltea, Bucuresti, 20125, Romania|Spitalul Universitar de Urgenta Bucuresti, Bucuresti, 20125, Romania|Institutul Clinic Fundeni, Bucuresti, 22328, Romania|Institutul Oncologic ""Prof. Dr. Ion Chiricuţă"" Cluj Napoca, Cluj-Napoca, 400124, Romania|Spitalul Clinic Municipal Filantropia Craiova, Craiova, 200143, Romania|Spitalul Clinic Judetean de Urgenta Târgu-Mureş (4005), Târgu-Mureş, 540042, Romania|Spitalul Clinic Judetean de Urgenta Târgu-Mureş (4008), Târgu-Mureş, 540136, Romania|Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, 603126, Russian Federation|Penza Regional Oncology Dispensary, Penza, 440071, Russian Federation|Republican Hospital n.a.V.A. Baranov, Petrozavodsk, 185019, Russian Federation|Ryazan Regional Clinical Hospital, Ryazan', 390039, Russian Federation|Almazov Federal North-West Medical Research Centre, Saint Petersburg, 197341, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, 410012, Russian Federation|Russian Research Institute of Hematology and Blood Transfusion, St. Petersburg, 191024, Russian Federation|Leningrad Regional Clinic and Hospital, St. Petersburg, 194291, Russian Federation|Tula Regional Clinical Hospital, Tula, 300053, Russian Federation|Klinički Centar Srbije, Belgrade, 11000, Serbia|Klinički Centar Niš, Nis, 18000, Serbia|Klinički Centar Vojvodine, Novi Sad, 21101, Serbia|National University Hospital (S) Pte Ltd, Singapore, 119074, Singapore|Singapore General Hospital, Singapore, 138543, Singapore|Hospital Universitari Son Espases, Palma, Mallorca, 7014, Spain|Complejo Hospitalario Universitario de Albacete - Hospital General Universitario, Albacete, 2006, Spain|Hospital General Universitario de Alicante, Alicante, 3010, Spain|Catalan Institute of Oncology (ICO), Badalona, 8916, Spain|Hospital del Mar, Barcelona, 8003, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 8035, Spain|Hospital Clinic i Provincial, Barcelona, 8036, Spain|Hospital Duran i Reynals, Barcelona, 8907, Spain|Hospital de Basurto, Bilbao, 48013, Spain|Hospital San Pedro de Alcántara, Cáceres, 10002, Spain|Hospital Universitario Reina Sofía, Córdoba, 14004, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, 17007, Spain|Complejo Hospitalario Universitario Granada, Granada, 18014, Spain|Complexo Hospitalario Universitario A Coruña, La Coruña, 15006, Spain|Hospital Dr. Negrín, Las Palmas De Gran Canaria, 35010, Spain|Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Quirón Madrid, Madrid, 28223, Spain|Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda, 28222, Spain|Hospital Regional Universitario de Málaga - Hospital General, Málaga, 29010, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|Complejo Hospitalario de Navarra, Pamplona, 31008, Spain|Fundación Jiménez Díaz, Pamplona, 31008, Spain|Hospital Clínico Universitario ""Lozano Blesa"", Pamplona, 31008, Spain|Hospital General Universitario Morales Meseguer, Pamplona, 31008, Spain|Hospital Universitario Miguel Servet, Pamplona, 31008, Spain|Hospital Álvaro Cunqueiro, Pamplona, 31008, Spain|Hosp Universitario Salamanca, Salamanca, 37007, Spain|Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain|Complexo Hospitalario Universitario de Santiago (CHUS) - Hospital Clínico Universitario, Santiago de Compostela, 15706, Spain|Hospital Universitario Virgen del Rocío, Sevilla, 41013, Spain|Hospital Universitari Joan XXIII de Tarragona, Tarragona, 43005, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Hospital Universitario Dr. Peset, Valencia, 46017, Spain|Hospital Universitari i Politècnic La Fe, Valencia, CP 46026, Spain|Chang Gung Medical Foundation - Kaohsiung Branch, Kaohsiung, Niaosong District, 83301, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Medical Foundation - Linkou Branch, Taoyuan, 33305, Taiwan|Cherkasy Regional Oncology Dispensary, Cherkasy, 18009, Ukraine|Poltava Regional Clinical Hospital named after M. V. Sklifosovskoho, Poltava, 36011, Ukraine|Vinnitsa Regional Clinical Hospital im. N.I. Pirogov, Vinnytsia, 21018, Ukraine|Zhitomir Regional Clinical Hospital, Zhytomyr, 10002, Ukraine|Maidstone and Tunbridge Wells NHS Trust - Maidstone Hospital, Maidstone, ME16 9QQ, United Kingdom","Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/53/NCT02668653/Prot_SAP_000.pdf"
